Vestibular function for children with insulin dependent diabetes using cervical vestibular evoked myogenic potentials testing

Table 3 Cervical vestibular evoked myogenic potential's results for children with type 1 diabetes in relation to their demographic, clinical and laboratory variables

Variables	P1	N1	P1-N1 amplitude	AR
Sex
Male (n = 10)	22.35 ± 1.12	26.32 ± 2.30	44.82	10.33
P1	0.02	0.320	0.01	0.01
Female (n = 30)	18.22 ± 1.63	32.55 ± 1.22	38.36	16.85
P1	0.04	0.01	0.001	0.001
P2	0.125	0.01	0.06	0.126
Duration of diabetes, yr
≤ 5 yr (n = 9)	16.68 ± 1.23	22.65 ± 2.22	38.30	6.50
P1	0.02	0.244	0.03	0.05
> 5 yr (n = 31)	28.33 ± 1.11	35.07 ± 2.31	56.26	18.68
P1	0.01	0.01	0.001	0.0001
P2	0.006	0.01	0.001	0.452
Dizziness
Yes (n = 6)	26.03 ± 1.33	34.68 ± 2.57	38.64	10.64
P1	0.002	0.01	0.001	0.01
No (n = 32)	16.23 ± 1.28	28.05 ± 2.28	56.00	16.28
P1	0.138	0.302	0.001	0.001
P2	0.02	0.03	0.01	0.06
Hb1Ac, %
≤ 7 (n = 4)	16.83 ± 1.30	22.01 ± 1.20	60.00	8.64
P1	0.306	0.358	0.08	0.023
> 7 (n = 36)	25.633 ± 1.28	34.55 ± 1.33	32.50	18.28
P1	0.04	0.01	0.001	0.804
P2	0.01	0.01	0.001	0.246
DKA
Yes (n = 22)	27.23 ± 1.20	34.25 ± 1.88	38.50	16.35
P1	0.01	0.01	0.001	0.001
No (n = 18)	14.84 ± 1.11	21.15 ± 1.23	55.84	8.00
P1	0.358	0.682	0.01	0.04
P2	0.003	0.001	0.01	0.323
Hypoglycemia	26.86 ± 1.80	34.22 ± 2.02	30.40	12.86
Yes (n = 12)
P1	0.01	0.01	0.001	0.01
No (n = 28)	16.50 ± 1.44	25.24 ± 2.562	54.68	10.35
P1	0.05	0.05	0.01	0.01
P2	0.02	0.03	0.03	0.286
Peripheral neuropathy
Yes (n = 16)	23.28 ± 1.30	32.26 ± 1.45	35.06	16.60
P1	0.001	0.01	0.001	0.01
No (n = 24)	16.44 ± 1.03	24.24 ± 1.40	52.66	13.44
P1	0.458	0.542	0.01	0.01
P2	0.02	0.03	0.02	0.322
Control subjects	13.22 ± 1.30	23.82 ± 1.37	74.68	4.88

DKA: Diabetic ketoacidosis; P1: Significance vs controls; P2: Significance for a vs b for each variable.